Researcher in Pathogenesis of Kidney Diseases to Speak on Genetic Discoveries

Full access
F1

Kirk N. Campbell, MD, FASN

Citation: Kidney News 16, 10/11

A researcher known globally for his work in the genetics of kidney diseases will deliver the Michelle P. Winn, MD, Endowed Lectureship on Friday, October 25. Kirk N. Campbell, MD, FASN, will present a lecture titled “APOL1-Mediated Kidney Disease: Variably Proteinuric, Yet Invariably Progressive.”

Dr. Campbell is the Irene and Dr. Arthur M. Fishberg Professor of Medicine in the Division of Nephrology and professor of pharmacological sciences at the Icahn School of Medicine at Mount Sinai in New York City. He is the founding director of the Mount Sinai Center for Kidney Disease Innovation, which has the goal of leveraging state-of-the-art genomic, bioinformatics, and molecular phenotyping technology to identify novel therapeutic targets for drug discovery and biomarker validation while expanding patient registries, biobanking, and clinical trial opportunities.

Dr. Campbell leads a National Institutes of Health-funded research program focused on podocyte cell biology, glomerular disease, and clinical trials in the rare kidney disease space. The work centers on advancing the understanding of the underlying mechanisms involved in kidney disease progression while identifying targets for therapeutic intervention and has resulted in two patents.

Dr. Campbell cochaired the ASN Kidney Week 2022 Education Committee and served on the American Kidney Fund group focused on advancing strategies for inclusive clinical trial enrollment. He has been a principal investigator for multiple clinical trials, testing novel agents to treat focal segmental glomerulosclerosis, immunoglobulin A nephropathy, lupus nephritis, and membranous nephropathy. He leads Mount Sinai's kidney precision medicine recruitment site, overseeing the safe and ethical collection of kidney biopsies, clinical data, and samples from patients with acute kidney injury and chronic kidney disease.

He is the president-elect of the National Kidney Foundation. He is a past president of The New York Society of Nephrology and a member of the board of directors of the NephCure Foundation. Dr. Campbell is also a member of the editorial boards of the American Journal of Kidney Diseases, Kidney360, Kidney International, Frontiers in Medicine, and the American Journal of Physiology–Renal Physiology. Among many honors, he received an ASN Distinguished Leader Award.

Dr. Campbell received his MD from the University of Connecticut School of Medicine, followed by an internal medicine residency at Yale New Haven Hospital and a nephrology fellowship at the Icahn School of Medicine at Mount Sinai.

Save